Companies House · 01118740

NOVO NORDISK LIMITED

UK registered company, private limited company, incorporated 18 Jun 1973.

Active
50
Public contracts
0
Spend payments
Total spend

NOVO NORDISK LIMITED is a UK company registered at Companies House under number 01118740. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
01118740
Status
Active
Company type
Private Limited Company
Incorporated
18 Jun 1973
Country of origin
United Kingdom
Registered office
3 CITY PLACE, GATWICK, WEST SUSSEX, RH6 0PA, UNITED KINGDOM
Nature of business (SIC)
46460 - Wholesale of pharmaceutical goods
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to NOVO NORDISK LIMITED.

ProcurementBuyerAwardedValue
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024NHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated ProductsSupply Chain Coordination Ltd (SCCL)
NP49024 Growth HormoneThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49024 Growth HormoneThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS Framework Agreement for Branded Medicines - National TenderNHS England
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England30 May 2024£765m
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024NHS England30 May 2024£765m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
Integrated Weight Management Services Pathway Redesign for NHS Mid and South Essex Integrated Care BoardAttain31 Dec 2022£201k
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
Bleeding Disorders including Haemophilia BNHS England14 Jun 2022£250m
Bleeding Disorders including Haemophilia BNHS England14 Jun 2022£250m
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework, North of England, Branded Medicines-Tranche A and Annual TrancheNHS England11 Feb 2021£1
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (DHSC)13 Sept 2020£53.1m
Supportive Medicines including ITU, EOL & AntibioticsHealth Family13 Sept 2020£53.1m
Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (DHSC)13 Sept 2020£53.1m
Supportive Medicines including ITU, EOL & AntibioticsDepartment of Health and Social Care (DHSC)13 Sept 2020£53.1m
Supportive Medicines including ITU, EOL & AntibioticsHealth Family13 Sept 2020£53.1m
NHS Framework for the NHS London Region, Branded Medicines - Tranche ANHS England16 Jun 2020£191.1m

Supplier identities

How this company appears as a supplier across the data.

FAQs about NOVO NORDISK LIMITED

Is NOVO NORDISK LIMITED an active company?

NOVO NORDISK LIMITED (company number 01118740) is recorded as "Active", incorporated on 18 Jun 1973.

What does NOVO NORDISK LIMITED do?

Its Companies House nature-of-business (SIC) is: 46460 - Wholesale of pharmaceutical goods.

Has NOVO NORDISK LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is NOVO NORDISK LIMITED based?

Its registered office is 3 CITY PLACE, GATWICK, WEST SUSSEX, RH6 0PA, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable